Abstract:

Medicines have the potential to cause Adverse Drug Reactions (ADRs) and therefore the need for health professionals to detect and spontaneously report to the National Agency for Food and Drug Administration and Control (NAFDAC) for further actions to ensure patients and public safety. The study was conducted to ascertain the proportion and reporting procedures of ADRs reported by health professionals in the Government Hospitals in Katsina State, Nigeria. This was a cross-sectional survey of 392 health professionals randomly selected from the 19 secondary hospitals in Katsina state. Data were collected through a self-administered structured questionnaire from 18th January to 19th February 2021 with a 98.7% and 1.3% response rate. Data were analyzed using STATA software Version 15.0. Descriptive statistics were used to describe the background characteristics of respondents, and the outcome, such as the proportion of ADR reported summarized in percentages, frequencies, and charts. There was only a 28.3% ADRs reporting rate, and 25.1% of health professionals who saw an ADRs case reported it by completing the ADRs form. The level of knowledge on ADRs reporting procedures was 58.3% among respondents. The main systemic challenge with ADRs reporting was the lack of access to the reporting form for ADRs. Therefore, there is a need to improve access to the reporting form in all the hospitals.

Keywords: Adverse Drug Reaction Reporting, Government Hospitals, Health Professionals, Katsina state, Nigeria, Reporting Rate.

References:

[1] Smith-Marsh, D. E. (2016), Adverse Drug Reactions (Adverse Drug Effects). Merck Sharp & Dohme Corporation, 42(1), 12–16. Retrieved from http://www.msdmanuals.com/professional/clinical-pharmacology/adverse-drug-reactions/adverse-drug-reactions.

[2] Nwokike, J., & Eghan, K. (2010), Pharmacovigilance in Ghana: A Systems Analysis.

[3] Dodoo, A., & Olsson, S. (2011), The world medicines situation 2011 pharmacovigilance and safety of medicines. WHO/EMP/MIE/2011.2.7.

[4] Oshikoya, K. A., Awobusuyi, J.O., (2009), Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009 Aug 11; 9:14. doi: 10.1186/1472-6904-9-14.

[5] Okezie, O.O., Fawole, O.I., (2008), Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmaco Epidemiol Drug Saf. 2008; 17: 517-522.

[6] Ohaju-Obodo, J.O., Iribhogbe, O.I., (2010), Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria. Pharmaco Epidemiol Drug Saf. 2010; 19: 191-195.

[7] Güner, M. D., (2017)’ Incentives to Increase Pharmacovigilance Practices from an Educational and Ethical Point of View. Journal of Pharmacology & Clinical Research, 3(5).

[8] Ezeuko, A.Y., Ebenebe, U.E., Nnebue, C.C., Ndu, O.O., (2015), Adverse Drug Reaction Reporting by Different Categories of Healthcare Workers in Nnewi, Nigeria: Awareness, Knowledge and Attitudes; BJMMR, 7(11): 932-941, 2015.

[9] World Health Organization. (2002), The Importance of Pharmacovigilance - Safety Monitoring of medicinal products. World Health Organization, 1–52. https://doi.org/10.1002/0470853093.

[10] Hazell, L., Shakir, S.A., (2006). Under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2006; 29:385-396.

[11] State News Letter (SNL) (2005), Addressing Maternal Mortality. Aminia 14: 5-13.

[12] Cochran, W.G., (1963), Sampling Techniques, Wiley, New York.

[13] Amedome, S.N., (2017), Pharmacovigilance Practices: Knowledge and Attitudes among the Healthcare Professionals at the Volta Regional Hospital of Ghana. https://doi.org/10.4172/2329-6887.1000229.

[14] Ekmekci, P. E., (2019), Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. 8(1), 13–20. https://doi.org/10.1080/21556660.2019.1566137.

[15] Sabblah, G. T., Akweongo, P., Darko, D. M., Dodoo, A. N. O., & Sulley, A. M. (2014), Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Medical Journal, 48(4), 189–193. https://doi.org/10.4314/gmj.v48i4.4.

[16] Bahekar, S. E., & Patil, S. M., (2018), Evaluation of knowledge, attitude, and practice of adverse drug reactions reporting among doctors and nursing staff of a rural tertiary care teaching hospital of Maharashtra. https://doi.org/10.4103/JMISR.JMISR.

[17] Kopciuch, D., Paczkowska, A., & Ratajczak, P., (2019), Safety of medicines — Pharmacists’ knowledge, practice, and attitudes toward
pharmacovigilance and adverse drug reactions reporting process. (August 2018), 1–9. https://doi.org/10.1002/pds.4792.

[18] Bello, S., Tukur, U. M., (2011), Original Article Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north- western Nigeria. https://doi.org/10.4103/1596-3519.76563.

[19] Almandil, N.B, (2016), Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance. Saud Med J.;37(12):1359–64.

[20] Qassim, S., Metwaly, Z., Shamsain, M., and Al-Hariri, Y., (2014), Spontaneous Reporting of Adverse Drug Reactions in UAE: Obstacles and Motivation among Community Pharmacists. Qassim et al., 5(10), 4203–4208. https://doi.org/10.13040/IJPSR.0975-8232.5(10).4203-08.

[21] Katusiime, B., Semakula, D., & Lubinga, S., (2015), Adverse drug reaction reporting among healthcare workers at Mulago National Referral and Teaching hospital in Uganda. Afri Health Sci., 15(4):1308-1317. [Online] Available at http://dx.doi.org/10.4314/ahs.v15i4.34.

[22] Jacobs, T. G., Hilda Ampadu, H., Hoekman, J., Dodoo, A. N. O., & Mantel-Teeuwisse, A. K., (2018), The contribution of Ghanaian patients to the reporting of adverse drug reactions: A quantitative and qualitative study. BMC Public Health, 18(1), 1–11. https://doi.org/10.1186/s12889-018-6285-9.